INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 121 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $241,000 | -81.7% | 70,431 | -84.0% | 0.03% | -82.3% |
| Q2 2021 | $1,320,000 | -22.9% | 441,473 | -16.7% | 0.19% | -44.1% |
| Q1 2021 | $1,712,000 | +5606.7% | 530,000 | +2255.6% | 0.33% | +16550.0% |
| Q2 2016 | $30,000 | -88.2% | 22,500 | -25.0% | 0.00% | -80.0% |
| Q3 2015 | $254,000 | +247.9% | 30,000 | +451.7% | 0.01% | +233.3% |
| Q3 2014 | $73,000 | -92.5% | 5,438 | -92.2% | 0.00% | -95.2% |
| Q4 2013 | $967,000 | +104.0% | 70,000 | +139.8% | 0.06% | +93.8% |
| Q2 2013 | $474,000 | – | 29,188 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,476,000 | $819,180 | 0.18% |
| BVF INC/IL | 6,353,645 | $3,526,273 | 0.15% |
| Gratus Capital, LLC | 1,323,598 | $734,600 | 0.06% |
| Bleichroeder LP | 250,000 | $138,750 | 0.03% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $302,757 | 0.01% |
| Callan Capital, LLC | 158,500 | $87,968 | 0.01% |
| Polar Capital Holdings Plc | 2,071,242 | $1,149,539 | 0.01% |
| Virtu Financial LLC | 66,537 | $37 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $138,195 | 0.00% |
| Pacific Sage Partners, LLC | 17,500 | $9,713 | 0.00% |